Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases is a research paper published in Frontiers in Immunology (2023). On theSindex it has a DataRank of 0.648. It has been cited 74 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.648
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: CA238263, CA229784, CA257267
European Commission
Grant: 257267
Steep subthreshold slope switches for energy efficient electronics
National Institutes of Health
Grant: 5R01CA238263-03
The effects of PD-1 on tumor-mediated “emergency” myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity
National Institutes of Health
Grant: 5R01CA229784-04
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
NCI NIH HHS
Grant: R01 CA229784
NCI NIH HHS
Grant: R01 CA238263
NCI NIH HHS
Grant: R01 CA257672
NCI NIH HHS
Grant: R01 CA271601
FWCI
8.67
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals